Status:
COMPLETED
Investigation of Fatigue, Physical Activity, Sleep Quality and Anxiety Levels
Lead Sponsor:
Ankara Yildirim Beyazıt University
Conditions:
Multiple Sclerosis
Covid-19
Eligibility:
All Genders
21-58 years
Brief Summary
Hundreds of thousands of confirmed cases have been reported worldwide, just 3 months after the first patients were identified in Wuhan, China. Just like other members of the community, MS patients are...
Eligibility Criteria
Inclusion
- patients with a confirmed diagnosis of clinically definite MS, physician-administered Expanded Disability Status Scale (EDSS) range of 1-5, and following the instructions.
Exclusion
- patients with acute attacks (three months prior to the study) and those included on the physiotherapy program during the Covid-19 pandemic.
Key Trial Info
Start Date :
May 5 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 18 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04438954
Start Date
May 5 2020
End Date
June 18 2020
Last Update
June 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara Yıldırım Beyazıt University, Faculty of Health Sciences,Department of Physiotherapy and Rehabilitation
Ankara, Turkey (Türkiye)